Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

Related Articles by Review for PubMed (Select 22762024)

1.

Genomics and bioinformatics of Parkinson's disease.

Scholz SW, Mhyre T, Ressom H, Shah S, Federoff HJ.

Cold Spring Harb Perspect Med. 2012 Jul;2(7):a009449. doi: 10.1101/cshperspect.a009449. Review.

2.

Role of genomics in translational research for Parkinson's disease.

Sekiyama K, Takamatsu Y, Waragai M, Hashimoto M.

Biochem Biophys Res Commun. 2014 Sep 19;452(2):226-35. doi: 10.1016/j.bbrc.2014.06.028. Epub 2014 Jun 17. Review.

PMID:
24950403
3.

Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.

Singh MP, Patel S, Dikshit M, Gupta YK.

Indian J Biochem Biophys. 2006 Apr;43(2):69-81. Review.

PMID:
16955754
4.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
5.

[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].

Hattori N.

Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Review. Japanese.

PMID:
15287506
6.

Genetic variability in SNCA and Parkinson's disease.

Pihlstrøm L, Toft M.

Neurogenetics. 2011 Nov;12(4):283-93. doi: 10.1007/s10048-011-0292-7. Epub 2011 Jul 29. Review.

PMID:
21800132
7.

The agony and ecstasy of "OMIC" technologies in drug development.

Bilello JA.

Curr Mol Med. 2005 Feb;5(1):39-52. Review.

PMID:
15720269
8.

Genetics of Parkinson's disease.

Kumar KR, Djarmati-Westenberger A, Grünewald A.

Semin Neurol. 2011 Nov;31(5):433-40. doi: 10.1055/s-0031-1299782. Epub 2012 Jan 21. Review.

PMID:
22266881
9.

Promoting synergistic research and education in genomics and bioinformatics.

Yang JY, Yang MQ, Zhu MM, Arabnia HR, Deng Y.

BMC Genomics. 2008;9 Suppl 1:I1. doi: 10.1186/1471-2164-9-S1-I1. Review.

10.

Genomic aspects of sporadic Parkinson's disease.

Riederer P, Youdim MB, Mandel S, Gerlach M, Grünblatt E.

Parkinsonism Relat Disord. 2008;14 Suppl 2:S88-91. doi: 10.1016/j.parkreldis.2008.04.009. Epub 2008 Jun 27. Review.

PMID:
18585078
11.

Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.

Nass R, Merchant KM, Ryan T.

Mol Interv. 2008 Dec;8(6):284-93. doi: 10.1124/mi.8.6.6. Review.

PMID:
19144901
12.

Molecular genetic pathways in Parkinson's disease: a review.

Jain S, Wood NW, Healy DG.

Clin Sci (Lond). 2005 Oct;109(4):355-64. Review.

PMID:
16171459
13.

Heredity in Parkinson's disease: new findings.

Lev N, Melamed E.

Isr Med Assoc J. 2001 Jun;3(6):435-8. Review.

14.

Molecular pathways and genetic aspects of Parkinson's disease: from bench to bedside.

Di Napoli M, Shah IM, Stewart DA.

Expert Rev Neurother. 2007 Dec;7(12):1693-729. Review.

PMID:
18052765
15.

Genetics of Parkinson's disease.

Klein C, Westenberger A.

Cold Spring Harb Perspect Med. 2012 Jan;2(1):a008888. doi: 10.1101/cshperspect.a008888. Review.

16.

Chemical genomics and emerging DNA technologies in the identification of drug mechanisms and drug targets.

Olsen LC, Færgeman NJ.

Curr Top Med Chem. 2012;12(12):1331-45. Review.

PMID:
22690680
17.

Systems biology of kidney diseases.

He JC, Chuang PY, Ma'ayan A, Iyengar R.

Kidney Int. 2012 Jan;81(1):22-39. doi: 10.1038/ki.2011.314. Epub 2011 Aug 31. Review.

18.

Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs.

Mandel S, Weinreb O, Youdim MB.

Trends Pharmacol Sci. 2003 Apr;24(4):184-91. Review.

PMID:
12707005
19.

Mitochondrial pathology in Parkinson's disease.

Schapira AH.

Mt Sinai J Med. 2011 Nov-Dec;78(6):872-81. doi: 10.1002/msj.20303. Review.

PMID:
22069211
20.

Taking a functional genomics approach in molecular medicine.

Yaspo ML.

Trends Mol Med. 2001 Nov;7(11):494-501. Review.

PMID:
11689334
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk